Article info
Clinical science
Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol
- Correspondence to Dr William R Freeman, Ophthalmology, Jacobs Retina Center, Shiley Eye Institute, University of California San Diego, San Diego, CA 92093, USA; wrfreeman{at}ucsd.edu
Citation
Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol
Publication history
- Received October 25, 2018
- Revised March 11, 2019
- Accepted March 27, 2019
- First published July 13, 2019.
Online issue publication
June 25, 2020
Article Versions
- Previous version (25 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.